GM23780
Fibroblast from Skin, Unspecified
Description:
EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT; EDMD2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
ENGLISH/DANISH/GERMAN/FRENCH/CANADIAN/IRISH
|
Family Member
|
1
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
4.45 |
Passage Frozen |
6 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
LMNA |
Chromosomal Location |
1q21.2 |
Allelic Variant 1 |
L35P; EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT |
Identified Mutation |
LEU35PRO |
Remarks |
Clinically affected; diagnostic muscle biopsy; achieved most motor function milestones and then lost them; donor subject is heterozygous for a de novo T>C transition at nucleotide 104 in exon 1 of the LMNA gene (104T>C) resulting in the substitution of proline for leucine at codon 35 [Leu35Pro (L35P)]. |
DuBose AJ, Lichtenstein ST, Petrash NM, Erdos MR, Gordon LB, Collins FS, Everolimus rescues multiple cellular defects in laminopathy-patient fibroblasts Proceedings of the National Academy of Sciences of the United States of America115:4206-4211 2018 |
PubMed ID: 29581305 |
Cumulative PDL at Freeze |
9.1 |
Passage Frozen |
6 |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Supplement |
- |
|
|